Identifying gait differences between Alzheimer's disease and dementia with Lewy bodies and their associations with regional amyloid deposition
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.14351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Salma Elasfar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Kinesiology and Health Sciences, University of Waterloo, Waterloo, Ontario, Canada. Hauptthemen laut MEDLINE: Lewy Body Disease, Alzheimer Disease, Gait, Amyloid beta-Peptides. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Parkinson's Canada, CIHR, NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION We aimed to compare gait between individuals with Alzheimer's disease (AD), dementia with Lewy bodies (DLB), and cognitively unimpaired (CU) individuals and to evaluate the association between gait and regional amyloid beta (Aβ) burden in AD and DLB. METHODS We included 420 participants (70 AD, 70 DLB, 280 CU) in the Mayo Clinic Study of Aging (MCSA). Gait was assessed using a pressure‐sensor walkway. Aβ deposition was analyzed with Pittsburgh compound B (PiB) positron emission topography (PET). RESULTS The DLB group had reduced stride velocity, step length, and stride width variability, as well as increased double support percentage (%DS) and variability in step length, swing time, and step time compared to the AD and CU groups. Aβ burden was not associated with any gait outcomes. DISCUSSION This study provides additional evidence that gait differs between AD and DLB. Larger studies are needed to investigate associations between Aβ burden and gait outcomes in dementia. Highlights Gait was more impaired in dementia than in cognitively unimpaired (CU) controls. Compared with Alzheimer's disease (AD), Dementia with Lewy bodies (DLB) had more impaired pace, variability, and postural control. Step length and double support (%) distinguished DLB and AD with moderate accuracy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Kinesiology and Health Sciences, University of Waterloo, Waterloo, Ontario, Canada.
- Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Psychiatry and Psychology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Salma Elasfar, Kaylena Ehgoetz Martens
Förderung
- Parkinson's Canada
- CIHR
- NIA NIH HHS
- National Institute of Health (NIH)
- Parkinson Society Canada
- the National Institute on Aging
- NINDS NIH HHS
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Elasfar, S., Hameed, H., Boeve, B. F., Fields, J. A., Jack, C. R., Kantarci, K., St Louis, E. K., Lowe, V. J., Petersen, R. C., Ali, F., & Ehgoetz Martens, K. (2025). Identifying gait differences between Alzheimer's disease and dementia with Lewy bodies and their associations with regional amyloid deposition. Alzheimer's & Dementia. https://doi.org/10.1002/alz.14351
Vancouver
Elasfar S, Hameed H, Boeve BF, Fields JA, Jack CR, Kantarci K, et al. Identifying gait differences between Alzheimer's disease and dementia with Lewy bodies and their associations with regional amyloid deposition. Alzheimer's & Dementia. 2025. doi:10.1002/alz.14351
BibTeX
@article{Elasfar2025,
author = {Elasfar, Salma and Hameed, Hajr and Boeve, Bradley F and Fields, Julie A and Jack, Clifford R and Kantarci, Kejal and St Louis, Erik K and Lowe, Val J and Petersen, Ronald C and Ali, Farwa and Ehgoetz Martens, Kaylena},
title = {Identifying gait differences between Alzheimer's disease and dementia with Lewy bodies and their associations with regional amyloid deposition},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.14351}
}
EUVIMED